SCHEMBL2373426

SCHEMBL2373426

COc1cccc(CNC(=O)c2csc(Nc3ccncn3)n2)c1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 13/20 0.54
ROCK2 O75116 10/20 0.54
PRKACA P17612 3/20 0.53
CYP3A4 P08684 3/20 0.53
PRKX P51817 2/20 0.53
PRKCQ Q04759 2/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
GSK3A P49840 1/20 0.53
GSK3B P49841 1/20 0.53
CLK4 Q9HAZ1 1/20 0.53
GRK5 P34947 1/20 0.53
AURKA O14965 1/20 0.52
MMP13 P45452 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31681838 1.00 ROCK1 (0.54) ROCK1ROCK2PRKACACYP3A4PRKX
SCHEMBL2373405 0.89 CYP1A2 (0.58) ROCK1ROCK2CYP3A4CYP2D6CYP2C9
SCHEMBL29072859 0.85 MMP13 (0.48) ROCK1ROCK2PRKACAPRKXGSK3A
SCHEMBL669856 0.85 MMP13 (0.48) ROCK1ROCK2PRKACAPRKXGSK3A
SCHEMBL2374833 0.83 MPL (0.52) CYP3A4CYP2D6MMP13HPGDKMT2A
SCHEMBL21881739 0.83 SMN1; SMN2 (0.42) ROCK1ROCK2PRKACACYP3A4PRKX
SCHEMBL2373894 0.82 HTT (0.55) ROCK1ROCK2MMP13MAPTKMT2A
SCHEMBL31681851 0.82 HTT (0.55) ROCK1ROCK2MMP13MAPTKMT2A
SCHEMBL2373945 0.82 NAMPT (0.46) CYP3A4CYP2D6CYP2C9MAPTKMT2A
SCHEMBL24139180 0.81 SMN1; SMN2 (0.53) ROCK1ROCK2CYP3A4CYP2C9MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4585589-A2 STEM CELL CULTURES The Scripps Research Institute (US) 2025-07-16 EP disclosed
EP-4296270-B1 A COMPOSITION COMPRISING STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2025-06-18 EP disclosed
EP-4296270-A2 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2023-12-27 EP disclosed
EP-3936508-B1 A COMPOSITION COMPRISING STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2023-12-06 EP disclosed
EP-3936508-A1 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2022-01-12 EP disclosed
US-20210403862-A1 METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS THE SCRIPPS RESEARCH INSTITUTE 2021-12-30 US disclosed
US-20210403862-A1 METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS THE SCRIPPS RESEARCH INSTITUTE 2021-12-30 US disclosed
EP-3623374-B1 STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2021-09-08 EP disclosed
EP-3623374-B1 STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2021-09-08 EP disclosed
US-10975352-B2 Methods of enhancing cell survival of stem cells THE SCRIPPS RESEARCH INSTITUTE (US) 2021-04-13 US disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
WO-2010065721-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10975352-B2 Methods of enhancing cell survival of stem cells MCL1, BCL2, BCLAF1 ROCK1 2668/4885ROCK2 2381/4885PRKACA 3901/4885
US-20110294761-A1 STEM CELL CULTURES NES, CD44, MCL1 ROCK1 713/4885ROCK2 576/4885PRKACA 2534/4885
US-20210403862-A1 METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS MCL1, BCL2, BCLAF1 ROCK1 2668/4885ROCK2 2381/4885PRKACA 3901/4885
US-20110224233-A1 STEM CELL CULTURES NES, CD44, MCL1 ROCK1 713/4885ROCK2 576/4885PRKACA 2534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.